Phylo
PrivateLast Round
Seed
Feb 3, 2026
Est. Valuation
$53.21M
Total Funding Raised
$13.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Phylo operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Seed round in February 2026.
Phylo is a biotechnology and artificial intelligence company that provides an integrated biology environment with agentic AI to help scientists plan, author, and execute complex research tasks.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Data Integration, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phylo Comparables
Compare Phylo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dash Bio | 80% | |
| Watershed | 79% | |
| Causaly | 78% |
For institutional investors. Book with your work email.
Phylo Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phylo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| SV Angel | Seed |
| Zetta Venture Partners | Seed |
| Conviction | Seed |
| Valkyrie | Seed |
| Anthology Fund | Seed |
| Menlo Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
Grew 100% QoQ, from 12 to 24 employees.
- Aug 21, 2026
Grew 75% QoQ, from 12 to 21 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 22, 2026
On Oct 22nd '26 in California, Phylo, Inc. partners with Bayer AG to deploy Biomni Lab, and Phylo, Inc. plans to provide Bayer AG full access to the platform for drug-discovery workflows using literature and omics evidence.
- launchesSep 29, 2026
Phylo, Inc. launched Target Atlas, an agentic target-prioritization app that accelerates evidence gathering and links findings to sources, in California on Sep 29th '26; the public edition is free with a Biomni account.
For institutional investors. Book with your work email.
Phylo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phylo's valuation, stock price, and market status.
Is Phylo a public or private company?
Phylo is a private company.
What is the current stock price of Phylo?
Phylo is a private company, so its shares have no public market price. Caplight tracks Phylo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phylo worth (valuation)?
Phylo's valuation is estimated at $53.2M based on funding round data.
Can I buy Phylo stock?
Phylo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phylo's last funding round?
Phylo's most recent funding round was Seed on February 3, 2026.
Who are the main investors in Phylo?
Key investors in Phylo include Andreessen Horowitz.
Will Phylo IPO soon?
No public IPO plans have been announced for Phylo.
How can I track Phylo secondary market activity?
Caplight tracks bids, offers, and trades in Phylo's shares on secondary markets.